Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Biomx Inc
Biomx Inc logo

PHGE.U - Biomx Inc Reuters News

$9.79 0.0  0.0%

Sector
Healthcare
RiskRating
Size
Style
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6715
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions PHGE.U Dividends
Reuters News
All News Reuters News Company Announcements
BRIEF-Biomx Announces Positive Results Of A Phase 1A Pharmacokinetic Study For Inflammatory Bowel Disease/Primary Sclerosing Cholangitis Evaluating Delivery Of Oral BX002 Phage Therapy
2nd Feb News
AMEX RESUMED BIOMX INC UNT
25th Jan News
AMEX HALT ADDITIONAL INFORMATION LAST 8.15000
25th Jan News
BUZZ-BiomX Inc: Rises on therapy to target bacteria in colorectal cancer patients
10th Dec '20 News
BRIEF-Biomx Announces Preclinical Results Of Analysis Of Patient Samples And Engineering Of Phage For Therapeutic Applications In Colorectal Cancer
9th Dec '20 News
BRIEF-Biomx Inc Files For Mixed Shelf Of Up To $150 Million
4th Dec '20 News
AMEX RESUMED BIOMX INC ORD
18th Nov '20 News
AMEX HALT ADDITIONAL INFORMATION LAST 5.600000
18th Nov '20 News
BRIEF-BiomX Presents Preclinical Results Of Phage Targeting Klebsiella Pneumoniae For Primary Sclerosing Cholangitis And Inflammatory Bowel Disease
16th Nov '20 News
BRIEF-Biomx Reports Third Quarter 2020 Financial Results And Announces Expanded Portfolio Of Phage Therapy Candidates
12th Nov '20 News
BRIEF-BiomX Announces Dosing Of First Subject In Phase 1A Study Of BX002 Phage Therapy For Inflammatory Bowel Disease
4th Nov '20 News
AMEX HALT EQUIPMENT CHANGEOVER LAST 6.00000
2nd Nov '20 News
AMEX HALT EQUIPMENT CHANGEOVER LAST 6.800
2nd Nov '20 News
BRIEF-Biomx Presents Preclinical Data On Phage Targeting Multidrug Resistant Klebsiella Pneumoniae Bacteria At The Infectious Disease Society Of America Idweek Conference 2020
21st Oct '20 News
BUZZ-Biomx Inc: Rises on collaboration deal for inflammatory bowel disease treatment
2nd Sep '20 News
BRIEF-BiomX Enters Collaboration With Boehringer Ingelheim
2nd Sep '20 News
BRIEF-BiomX Says Net Loss Was $6.2 Million In Q2
13th Aug '20 News
BRIEF-Biomx Inc Says Results From Phase 2 Cosmetic Clinical Study Of BX001 Expected In Q2 Of 2021
14th May '20 News
AMEX RESUMED BIOMX INC ORD
7th May '20 News
AMEX HALT ADDITIONAL INFORMATION LAST 8.360000
7th May '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.